| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.004 | 1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |